Exhibit 4.3
PHARMACOPEIA DRUG DISCOVERY,
INC.
AMENDED AND RESTATED 2004 STOCK
INCENTIVE PLAN
Effective April 6,
2004
Effective as Amended and Restated
May , 2007
ARTICLE 1
PURPOSE AND TERM OF
PLAN
1.1. Purpose . The
purpose of the Plan is to provide motivation to selected Employees,
Directors and Consultants to put forth maximum efforts toward the
continued growth, profitability, and success of the Company by
providing incentives to such Employees, Directors and Consultants
through the ownership and performance of Common Stock.
1.2. Term . The
Plan was originally approved by the Board on March 16, 2004,
and became effective upon the date of the approval by
Pharmacopeia’s stockholders. This amendment and restatement
was approved by the Board on
,
2007 and becomes effective on the date of the approval by the
Company’s stockholders. The Plan and any Awards granted
thereunder shall be null and void if stockholder approval is not
obtained.
ARTICLE 2
DEFINITIONS
In any necessary construction of a
provision of this Plan, the masculine gender may include the
feminine, and the singular may include the plural, and vice
versa.
2.1. “ Affiliate
” means any entity other than the Subsidiaries in which
the Company has a substantial direct or indirect equity interest,
as determined by the Board.
2.2. “ Approved
Reason ” means a reason for terminating employment
with the Company, which, in the opinion of the Committee, is in the
best interests of the Company. The Committee must specifically
designate that a Participant has been terminated for an Approved
Reason. Absent such determination by the Committee, a Participant
cannot be found to have terminated for an Approved
Reason.
2.3. “ Award
” means any form of Option, SAR, Stock Award,
performance unit, performance share, or Performance Award, whether
singly, in combination, or in tandem, to a Participant by the
Committee pursuant to such terms, conditions, restrictions and/or
limitations, if any, as the Committee may establish by the Award
Notice or otherwise.
2.4. “ Award
Notice ” means the written document establishing the
terms, conditions, restrictions, and/or limitations of an Award in
addition to those established by this Plan and by the
Committee’s exercise of its administrative powers. The
Committee will establish the form of the written document in the
exercise of its sole and absolute discretion.
2.5. “ Board
” means the Board of Directors of the
Company.
2.6. “ Calendar Year
Subaccount ” means a notional bookkeeping account to
which all of a Participant’s deferred Awards are
credited.
2.7. “ Cause
” means, unless otherwise provided in an employment,
change in control, severance or similar agreement between a
Participant and the Company or in an Award Notice: (a) any
gross failure by the Participant (other than by reason of
Disability) to faithfully and professionally carry out his or her
duties or to comply with any other material provision of his or her
employment agreement, if any, which continues for thirty days after
written notice by the Company; provided, that the Company does not
have to provide notice in the event that the failure is not
susceptible to remedy or relates to the same type of acts or
omissions as to which notice has been given on a prior occasion;
(b) the Participant’s dishonesty or other willful
misconduct; (c) the Participant’s conviction of any
felony or of any other crime involving moral turpitude, whether or
not relating to his or her employment; (d) the
Participant’s insobriety or use of drugs, chemicals or
controlled substances either in the course of performing his or her
duties and responsibilities under his or her employment agreement
or otherwise affecting the ability of Participant to perform those
duties and responsibilities; (e) the Participant’s
failure to comply with a lawful written direction of the Company;
(f) any wanton or willful dereliction of duties by the
Participant; or (g) breach of the Company’s Code of
Ethics or insider trading policies.
2.8. “ CEO
” means the Chief Executive Officer of the
Company.
2.9. “ Change In
Control ” means: (i) any “person”
(within the meaning of Section 13(d) or 14(d) of the
Exchange Act, including a “group” within the meaning of
Section 13(d) but excluding the Company and any of its
Subsidiaries or Affiliates and any employee benefit plan sponsored
or maintained by the Company or any subsidiary thereof), shall
become the “beneficial owner” (as defined in
Rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of the Company representing thirty percent (30%) or
more of the combined voting power of the then outstanding
securities entitled to vote generally in the election of directors
(“Voting Securities”) of the Company (the
“Company Voting Securities”); or (ii) the
consummation of a merger, consolidation, reorganization or any
other business combination (any of the foregoing, a “Business
Combination”) of or involving the Company and another person
or persons where the persons who were the beneficial owners of
Company Voting Securities outstanding immediately prior to such
Business Combination do not beneficially own, directly or
indirectly, immediately after such transaction, securities
representing fifty percent (50%) or more of the combined
voting power of the then outstanding Company Voting Securities or
Voting Securities of the entity acquiring the Company in such
Business Combination; (iii) shareholder approval of a complete
liquidation or dissolution of the Company; or (iv) a sale,
lease, exchange or other disposition or transfer (in one
transaction or a series of related transactions) of all or
substantially all of the assets or business of the Company;
provided, that a change in control under this clause shall not be
deemed to have occurred where (x) the Company sells, exchanges
or otherwise disposes of or transfers all or substantially all of
its assets or business to another corporation which is beneficially
owned, directly or indirectly, immediately following such
transaction by the holders of Company Voting Securities in
substantially the same proportions as their ownership of Company
Voting Securities immediately prior to such transaction and
(y) such corporation assumes the Plan; or (v) during any
period of two consecutive years, the Continuing Directors (as
defined below) cease for any reason to constitute at least a
majority of the Board (or, if applicable, of a successor to the
Company), where the term “Continuing Director” means at
any date a director of the Company who was (x) a director at
the beginning of such period or (y) nominated or elected
subsequent to such date by at least a majority of the directors who
were Continuing Directors at the time of such nomination or
election or whose election to the board was recommended or endorsed
by at least a majority of the directors who were Continuing
Directors at the time of such nomination or election (it being
understood that no individual whose initial assumption of office
occurred as a result of an actual or threatened election contest
with respect to the election or removal of directors or other
actual or threatened solicitation of proxies or consents by or on
behalf of a person other than the board shall be a Continuing
Director).
2.10. “ Code
” means the Internal Revenue Code of 1986, as amended
from time to time, including regulations thereunder and successor
provisions and regulations thereto.
2.11. “ Committe
” means the Board or the committee designated by the
Board to administer the Plan under Article 4. The Committee
shall have at least two members, each of whom shall be a
“non-employee director” as defined in Rule 16b-3
under the Exchange Act and an “outside director” as
defined in Section 162(m) of the Code and the regulations
thereunder, and, if applicable meet the independence requirements
of the applicable stock exchange, quotation system or other
self-regulatory organization on which the Common Stock is traded.
Notwithstanding the foregoing, the Board may designate one or more
of its members to serve as a Secondary Committee and delegate to
the Secondary Committee authority to grant Awards to eligible
individuals who are not subject to the requirements of
Rule 16b-3 under the Exchange Act or
Section 162(m) of the Code and the regulations
thereunder. The Secondary Committee shall have the same authority
with respect to selecting the individuals to whom such Awards are
granted and establishing the terms and conditions of such Awards as
the Committee has under the terms of the Plan.
2.12. “ Common
Stock ” means the common stock, $0.01 par value per
share, of the Company that may be newly issued or treasury
stock.
2.13. “ Company
” means with respect to Employees and consultants,
Pharmacopeia and its Subsidiaries and Affiliates provided, however,
that with respect to Directors, Company shall only mean
Pharmacopeia.
2.14. “
Consultants ” means the consultants, advisors and
independent contractors retained by the Company.
2.15. “ Covered
Employee ” means an Employee who is a “Covered
Employee” within the meaning of Section 162(m) of
the Code.
2.16. “ Director
” means a non-Employee member of the Board.
2.17. “ Disability
” means a physical or mental impairment that satisfies
the definition of disability under Section 22(e)(3) of
the Code.
2.18. “ Effective
Date ” means the date an Award is determined to be
effective by the Committee upon its grant of such Award, which date
shall be set forth in the applicable Award Notice.
2.19. “ Employee
” means any person employed by the Company on a full or
part-time basis.
2.20. “ Exchange
Act ” means the Securities Exchange Act of 1934, as
amended from time to time, including rules thereunder and
successor provisions and rules thereto.
2.21. “ Fair Market
Value ” means on any given date:
(a) if the Common Stock is
listed on an established stock exchange or exchanges, the closing
price of Common Stock on the principal exchange on which it is
traded on such date, or if no sale was made on such date on such
principal exchange, on the last preceding day on which the Common
Stock was traded;
(b) if the Common Stock is not
then listed on an exchange, but is quoted on NASDAQ or a similar
quotation system, the closing price per share for the Common Stock
as quoted on NASDAQ or similar quotation system on such
date;
(c) if the Common Stock is not
then listed on an exchange or quoted on NASDAQ or a similar
quotation system, the value, as determined in good faith by the
Committee and in accordance with applicable provisions of the Code
or regulations and rulings thereunder.
2.22. “ Incentive
Stock Option ” means an Option which meets the
requirements of Section 422 of the Code and which is
designated as an Incentive Stock Option by the
Committee.
2.23. “ Negative
Discretion ” means the discretion authorized by the
Plan to be applied by the Committee in determining the size of an
Award for a Performance Period if, in the Committee’s sole
judgment, such application is appropriate. Negative Discretion may
only be used by the Committee to eliminate or reduce the size of an
Award. In no event shall any discretionary authority granted to the
Committee by the Plan, including, but not limited to Negative
Discretion, be used to: (a) grant Awards for a Performance
Period if the Performance Goals for such Performance Period have
not been attained under the applicable Performance Formula; or
(b) increase an Award above the maximum amount payable under
Section 6.3 of the Plan.
2.24. “ Non-Qualified
Stock Option ” means an Option not intended to be an
Incentive Stock Option, and designated as a Non-Qualified Stock
Option by the Committee.
2.25. “ Option
” means the right, granted from time to time under the
Plan, to purchase Common Stock for a specified period of time at a
stated price. An Option may be an Incentive Stock Option or a
Non-Qualified Stock Option.
2.26. “
Participant ” means either an Employee, Director
or Consultant to whom an Award has been granted by the Committee
under the Plan.
2.27. “ Performance
Awards ” means the Stock Awards, performance units
and performance shares granted to Covered Employees pursuant to
Article 7. All Performance Awards are intended to qualify as
“performance-based compensation” under
Section 162(m) of the Code.
2.28. “ Performance
Criteria ” means the one or more criteria that the
Committee shall select for purposes of establishing the Performance
Goal(s) for a Performance Period. The Performance Criteria
that will be used to establish such Performance Goal(s) shall
be limited to the following: revenue growth; earnings before
interest, taxes, depreciation and amortization (EBITDA); operating
income; net operating income after tax; pre- or after-tax income;
cash flow; cash flow per share; net earnings; earnings per share;
return on equity; return on capital employed; return on assets;
economic value added (or an equivalent metric); share price
performance; total shareholder return; improvement in or attainment
of expense levels; improvement in or attainment of working capital
levels; or debt reduction. To the extent required by
Section 162(m) of the Code, the Committee shall, within
the time period required by Section 162(m) of the Code
(generally, the first 90 days of a Performance Period), define in
an objective fashion the manner of calculating the Performance
Criteria it selects to use for such Performance Period.
2.29. “ Performance
Formula ” means, for a Performance Period, the one
or more objective formulas (expressed as a percentage or otherwise)
applied against the relevant Performance Goal(s) to determine,
with regards to the Award of a particular Participant, whether all,
some portion but less than all, or none of the Award has been
earned for the Performance Period.
2.30. “ Performance
Goals ” means, for a Performance Period, the one or
more goals established by the Committee for the Performance Period
based upon the Performance Criteria. Performance Goals may be based
on the performance of the Company, any Subsidiary or any division
or business unit within the Company or any Subsidiary, and if so
desired by the Committee, by comparison with a peer group of
companies. Unless otherwise stated, such Performance Goals, need
not be based upon an increase or positive result and could include,
for example, maintaining the status quo or limiting economic loss
(measured, in each case, by reference to specific Performance
Criteria.) The Committee is authorized at any time during the time
period permitted by Section 162(m) of the Code
(generally, the first 90 days of a Performance Period), or at any
time thereafter, in its sole and absolute discretion, to adjust or
modify the calculation of a Performance Goal for such Performance
Period in order to prevent the dilution or enlargement of the
rights of Participants, (a) in the event of, or in
anticipation of, any unusual or extraordinary corporate item,
transaction, event or development; (b) in recognition of, or
in anticipation of, any other unusual or nonrecurring events
affecting the Company, or the financial statements of the Company,
or in response to, or in anticipation of, changes in applicable
laws, regulations, accounting principles, or business conditions;
and (c) in view of the Committee’s assessment of the
business strategy of the Company, performance of comparable
organizations, economic and business conditions, and any other
circumstances deemed relevant.
2.31. “ Performance
Period ” means the one or more periods of time (of
at least 12 months), which may be of varying and overlapping
durations, as the Committee may select, over which the attainment
of one or more Performance Goals will be measured for the purpose
of determining a Participant’s right to and the payment of a
Performance Award.
2.32. “
Pharmacopeia ” means Pharmacopeia, Inc., a
Delaware corporation, formerly known as Pharmacopeia Drug
Discovery, Inc.
2.33. “ Plan
” means this Pharmacopeia, Inc. 2004 Stock
Incentive Plan, as amended from time to time.
2.34. “ Restricted
Stock ” means a Stock Award granted pursuant to
Article 11 subject to the restrictions provided in the
applicable Award Notice.
2.35. “ Retirement
” means, unless otherwise provided, a termination for
other than Cause after attaining at least age 55 and completing at
least 5 years of service with the Company.
2.36. “ SAR
”, or stock appreciation right, means the right to
receive, in cash or in Common Stock, as determined by the
Committee, the increase in the Fair Market Value of the Common
Stock underlying the SAR from the date of grant to the date of
exercise.
2.37. “ Stock
Award ” means an award granted pursuant to
Article 10 in the form of shares of Common Stock, Restricted
Stock, and/or Units of Common Stock.
2.38. “ Subsidiary
” means any corporation (other than Pharmacopeia) in an
unbroken chain of corporations beginning with Pharmacopeia (or any
subsequent parent of Pharmacopeia) if each of the corporations
other than the last corporation in the unbroken chain owns stock
possessing 50 percent or more of the total combined voting power of
all classes of stock in one of the other corporations in such
chain.
2.39. “ Ten Percent
Stockholder ” means a person who on any given date
owns, either directly or indirectly (taking into account the
attribution rules contained in Section 424(d) of the
Code), stock possessing more than 10 percent of the total combined
voting power of all classes of stock of the Company or any
Subsidiary.
2.40. “ Unit
” means a bookkeeping entry used by Company to record
and account for the grant of the following Awards until such time
as the Award is paid, canceled, forfeited or terminated, as the
case may be: Units of Common Stock, performance units, and
performance shares which are expressed in terms of Units of Common
Stock.
ARTICLE 3
ELIGIBILITY
3.1. In General
. Subject to Section 3.2, all Employees, Directors and
Consultants are eligible to participate in the Plan. The Committee
may select, from time to time, Participants from those Employees
and who, in the opinion of the Committee, can further the
Plan’s purposes. In addition, the Committee may select, from
time to time, Participants from those Directors and Consultants
(who may or may not be Committee members) who, in the opinion of
the Committee, can further the Plan’s purposes. Once a
Participant is so selected, the Committee shall determine the
type(s) of Awards to be made to the Participant and shall
establish in the related Award Notice(s) the terms,
conditions, restrictions and/or limitations, if any, applicable to
the Award(s) in addition to those set forth in this Plan and
the administrative rules and regulations issued by the
Committee.
3.2. Incentive Stock
Options . Only Employees shall be eligible to receive
“incentive stock options” (within the meaning of
Section 422 of the Code).
ARTICLE 4
PLAN
ADMINISTRATION
4.1. Members
. Members of the Committee shall be appointed by and hold
office at the pleasure of the Board. Committee members may resign
at any time by delivering written notice to the Board. Vacancies in
the Committee may be filled by the Board.
4.2. Responsibility
. The Committee shall have total and exclusive responsibility
to control, operate, manage and administer the Plan, in accordance
with its terms.
4.3. Authority of the
Committee . The Committee shall have all the authority
that may be necessary or helpful to enable it to discharge its
responsibilities with respect to the Plan. Without limiting the
generality of the preceding sentence, the Committee shall have the
exclusive right to: (a) select the Participants and determine
the type of Awards to be made to Participants, the number of shares
subject to Awards and the terms, conditions, restrictions and
limitations of the Awards; (b) interpret the Plan;
(c) determine eligibility for participation in the Plan;
(d) decide all questions concerning eligibility for and the
amount of Awards payable under the Plan; (e) construe any
ambiguous provision of the Plan; (f) correct any default;
(g) supply any omission; (h) reconcile any inconsistency;
(i) issue administrative guidelines as an aid to administer
the Plan and make changes in such guidelines as it from time to
time deems proper; (j) make regulations for carrying out the
Plan and make changes in such regulations as it from time to time
deems proper; (k) determine whether Awards should be granted
singly, in combination or in tandem; (l) to the extent
permitted under the Plan, grant waivers of Plan terms, conditions,
restrictions, and limitations, (m) accelerate the vesting,
exercise, or payment of an Award or the performance period of an
Award when such action or actions would be in the best interest of
the Company; (n) subject to Section 17.3, grant Awards in
replacement of Awards previously granted under this Plan or any
other executive compensation plan of the Company;
(o) establish; and administer the-Performance Goals and
certify whether, and to what extent, they have been attained;
(p) determine the terms and provisions of any agreements
entered into hereunder; (q) take any and all other action it
deems necessary or advisable for the proper operation or
administration of the Plan; and (r) make all other
determinations it deems necessary or advisable for the
administration of the Plan, including factual determinations.
Notwithstanding anything herein to the contrary and except as
expressly provided by the adjustment provisions of
Section 6.2, Options and SARs granted under the Plan shall not
be directly or indirectly repriced, replaced or regranted through
cancellation without shareholder approval, including, but not
limited to, an exchange of an Option or SAR with an exercise price
or base price less than Fair Market Value for cash, restricted
stock, stock options or other stock awards.
4.4. Discretionary
Authority . The Committee shall have full discretionary
authority in all matters related to the discharge of its
responsibilities and the exercise of its authority under the Plan
including, without limitation, its construction of the terms of the
Plan and its determination of eligibility for participation and
Awards under the Plan. It is the intent of Plan that the decisions
of the Committee and its actions with respect to the Plan shall be
final, binding and conclusive upon all persons having or claiming
to have any right or interest in or under the Plan.
4.5.
Section 162(m) of the Code . With regards to
all Covered Employees, the Plan shall, for all purposes, be
interpreted and construed in accordance with
Section 162(m) of the Code.
4.6. Action by the
Committee . The Committee may act at a meeting only by a
majority of its members. Any determination of the Committee may be
made, without a meeting, by a writing or writings signed by all of
the members of the Committee. In addition, the Committee may
authorize any one or more of its number to execute and deliver
documents on behalf of the Committee.
4.7. Allocation and
Delegation of Authority . The Committee may allocate all
or any portion of its responsibilities and powers under the Plan to
any one or more of its members, the CEO or the Secondary Committee
as the Committee deems appropriate and may delegate all or any part
of its responsibilities and powers to any such person or persons,
provided that any such allocation or delegation be in writing;
provided, however, that only the Committee may select and grant
Awards to Participants who are subject to Section 16 of the
Exchange Act or are Covered Employees. The Committee may revoke any
such allocation or delegation at any time for any reason with or
without prior notice.
ARTICLE 5
FORM OF
AWARDS
5.1. In General
. Awards may, at the Committee’s sole discretion, be
granted in the form of Performance Awards pursuant to
Article 7, Options pursuant to Article 8, SARs pursuant
to Article 9, Stock Awards pursuant to Article 10,
performance units pursuant to Article 11, performance shares
pursuant to Article 12, or a combination thereof. All Awards
shall be subject to the terms, conditions, restrictions and
limitations of the Plan. The Committee may, in its sole judgment,
subject an Award at any time to such other terms, conditions,
restrictions and/or limitations, (including, but not limited to,
the time and conditions of exercise and restrictions on
transferability and vesting), provided they are not inconsistent
with the terms of the Plan. Awards under a particular
Article of the Plan need not be uniform and Awards under two
or more Articles may be combined into a single Award Notice. Any
combination of Awards may be granted at one time and on more than
one occasion to the same Participant.
5.2. Foreign
Jurisdictions .
(a) Special Terms.
In order to facilitate the making of any Award to
Participants who are employed or retained by the Company outside
the United States as Employees, Directors or Consultants (or who
are foreign nationals temporarily within the United States), the
Committee may provide for such modifications and additional terms
and conditions (“special terms”) in Awards as the
Committee may consider necessary or appropriate to accommodate
differences in local law, policy or custom or to facilitate
administration of the Plan. The special terms may provide that the
grant of an Award is subject to (1) applicable governmental
or, regulatory approval or other compliance with local legal
requirements and/or (2) the execution by the Participant of a
written instrument in the form specified by the Committee, and that
in the event such conditions are not satisfied, the grant shall be
void. The special terms may also provide that an Award shall become
exercisable or redeemable, as the case may be, if an
Employee’s employment or Director or Consultant’s
relationship with the Company ends as a result of workforce
reduction, realignment or similar measure and the Committee may
designate a person or persons to make such determination for a
location. The Committee may adopt or approve sub-plans, appendices
or supplements to, or amendments, restatements, or alternative
versions of, the Plan as it may consider necessary or appropriate
for purposes of implementing any special terms, without thereby
affecting the terms of the Plan as in effect for any other purpose;
provided, however, no such sub-plans, appendices or supplements to,
or amendments, restatements, or alternative versions of, the Plan
shall: (a) increase the limitations contained in
Section 6.3; (b) increase the number of available shares
under Section 6.1; (c) cause the Plan to cease to satisfy
any conditions of Rule 16b-3 under the Exchange Act or, with
respect to Covered Employees whose compensation is subject to
Section 162(m) of the Code, Section 162(m) of
the Code; or (d) revoke, remove or reduce any vested right of
a Participant without the prior written consent of such
Participant.
(b) Currency Effects.
Unless otherwise specifically determined by the Committee,
all Awards and payments pursuant to such Awards shall be determined
in U.S. currency. The Committee shall determine, in its discretion,
whether and to the extent any payments made pursuant to an Award
shall be made in local currency, as opposed to U.S. dollars. In the
event payments are made in local currency, the Committee may
determine, in its discretion and without liability to any
Participant, the method and rate of converting the payment into
local currency.
(c) Modifications to
Awards. The Committee shall have the right at any time
and from time to time and without prior notice to modify
outstanding Awards to comply with or satisfy local laws and
regulations or to avoid costly governmental filings. By means of
illustration, but not limitation, the Committee may restrict the
method of exercise of an Award to facilitate compliance with
applicable securities laws or exchange control filings, laws or
regulations.
(d) No Acquired Rights.
No Employee in any country shall have any right to receive an
Award, except as expressly provided for under the Plan. All Awards
made at any time are subject to the prior approval of the
Committee.
ARTICLE 6
SHARES SUBJECT TO
PLAN
6.1. Available Shares
. The maximum number of shares of Common Stock which shall be
available for grant of Awards under the Plan (including Incentive
Stock Options) during its term shall not exceed 3,400,000. All of
the shares of Common Stock reserved hereunder may be issuable as
Incentive Stock Options. Such amount shall be subject to adjustment
as provided in Section 6.2. Any shares of Common Stock related
to Awards which terminate by expiration, forfeiture, cancellation
or otherwise without the issuance of such shares, are settled in
cash in lieu of Common Stock, or are exchanged with the
Committee’s permission for Awards not involving Common Stock,
shall be available again for grant under the Plan. Moreover, if the
exercise price of any Option or the tax withholding requirements
with respect to any Option, Stock Award or performance share or
performance unit award are satisfied by tendering shares of Common
Stock to the Company (by either actual delivery or by attestation),
only the number of shares of Common Stock issued net of the shares
of Common Stock tendered or withheld will be deemed delivered for
purposes of determining the maximum number of shares of Common
Stock available for delivery under the Plan. The maximum number of
shares available for issuance under the Plan shall not be reduced
to reflect any dividends or dividend equivalents that are
reinvested into additional shares, of Common Stock or credited as
additional performance shares. The maximum number of shares of
Common Stock shall not be reduced by the issuance of shares of
Common Stock hereunder due to the assumption, conversion or
substitution of awards made by an entity acquired by the Company.
The shares of Common Stock available for issuance under the Plan
may be authorized and unissued shares or treasury shares. For the
purpose of computing the total number of shares of Common Stock
granted under the Plan, where one or more types of Awards, both of
which are payable in shares of Common Stock, are granted in tandem
with each other, such that the exercise of one type of Award with
respect to a number of shares cancels an equal number of shares of
the other, the number of shares granted under both Awards shall be
deemed to be equivalent to the number of shares under one of the
Awards.
6.2. Adjustment to
Shares . The provisions of this
Section 6.2(a) are subject to the limitation contained in
Section 6.2(b). If there is any change in the number of
outstanding shares of Common Stock through the declaration of stock
dividends, stock splits or the like, the number of shares available
for Awards, the shares subject to any Award and the exercise prices
of Awards shall be automatically adjusted. If there is any change
in the number of outstanding shares of Common Stock through any
change in the capital account of the Company, or through a merger,
consolidation, separation (including a spin off or other
distribution of stock or property), reorganization (whether or not
such reorganization comes within the meaning of such term in
Section 368(a) of the Code) or partial or complete
liquidation, the Committee shall make appropriate adjustments in
the maximum number of shares of Common Stock which may be issued
under the Plan and any adjustments and/or modifications to
outstanding Awards. In the event of any other ch